Fig. 1
From: Downregulation of MAL2 inhibits breast cancer progression through regulating β-catenin/c-Myc axis
MAL2 is upregulated in BC tissues and is associated with poor prognosis. A Bioinformatic analyses of the MAL2 expression in BC tissues (n = 1085) and adjacent noncancerous tissues (n = 291) from GEPIA datasets. B The expression level of MAL2 in primary tumor tissues (n = 1097) and adjacent noncancerous tissues (n = 114) from the UALCAN database. C Kaplan-Meier analysis of the correlation between the MAL2 expression level and the overall survival of BC patients represented in the tissue array from GEPIA datasets. D Kaplan-Meier analysis of the correlation between the MAL2 expression level and the overall survival of BC patients represented in the tissue array from UALCAN database. E Representative immunohistochemical (IHC) staining images of MAL2 expression in BC (n = 21), fibroadenoma (n = 16) and adjacent normal tissues (n = 13). The scale bars in the 200× magnification images represent 100 μm. All data are represented as mean ± SD. ***P < 0.001